GLP-1 therapy
the way it should be done.

Yes — the medication price floor is identical because we use the same manufacturer programs. With qualifying commercial insurance and a Novo or Lilly savings card, Wegovy, Zepbound, or Foundayo can be as low as $25/mo. Without insurance, Foundayo starts at $149/mo, Zepbound at $299/mo (starter dose), and Wegovy injection at $199/mo for the first 2 fills (intro offer through Dec 2026), then $349/mo standard. We write prescriptions directly to NovoCare and LillyDirect — no middleman markup.

Your entire GLP-1 program is FSA and HSA eligible. If you have employer benefits with a flexible spending or health savings account, pre-tax dollars can reduce your effective out-of-pocket cost by 20–35%. We provide documentation for reimbursement.

No — and this is one of the most common misconceptions. We draw a one-time baseline metabolic panel before your first prescription. That's it. After that, follow-up labs are ordered only as clinically indicated — typically at 3 and 6 months to monitor progress. Labs are never a recurring monthly cost or burden.

A free consultation is a quick first step with no commitment — call 317-642-0211 or book online. We review your insurance coverage, health history, and goals, then confirm whether GLP-1 therapy is likely appropriate and what your cost would look like. Most patients hear back within 24 hours.

If your prior authorization gets denied, we don't stop there. We file appeals with supporting clinical documentation — labs, BMI, relevant comorbidities. Where applicable, we pursue a cardiovascular indication resubmission, since Wegovy has FDA approval for cardiovascular risk reduction in addition to weight management, which opens additional coverage pathways. If insurance ultimately doesn't come through, we move you to the best available cash-pay pricing.

Weekly in-office injections are an option, not a requirement. Many patients prefer to self-inject at home — we train you at your first visit. Either way, you stay in the same monitoring program with Dr. Milien.

The add-ons are designed specifically for GLP-1 patients. GLP-1 medications can reduce muscle mass alongside fat loss at higher doses. Red light therapy (Theralight 360+, wavelengths up to 960nm) supports muscle recovery, skin tightening, and body contouring. IV hydration with B12 or Lipo-Mino addresses the fatigue and nausea common in early titration while supporting body composition. Both are fully optional and available at any weekly visit.

Yes — Foundayo (orforglipron) is a once-daily oral pill, FDA-approved in April 2026. Unlike other oral GLP-1 options, it can be taken any time of day, with or without food or water restrictions. That's a meaningful difference. In clinical trials it delivered an average of 12.4% body weight reduction at the highest dose. For patients who want effective GLP-1 therapy without injections, Foundayo is a strong option. Cash pay starts at $149/mo through LillyDirect, or as low as $25/mo with qualifying commercial insurance.

Yes — transfers are straightforward and we do them regularly. We review your current prescription, draw baseline metabolic labs, perform a MenlaScan body composition assessment, and build a proper monitoring plan. In most cases you continue on the same medication without starting over.

Our office is at 8402 E 116th Street, Suite 100, Fishers, IN. Patients from Carmel, Noblesville, Westfield, and Geist are typically 15–20 minutes away. From downtown Indianapolis or Zionsville, about 30–35 minutes. Weekly injection visits are quick — most patients are in and out in under 30 minutes.